Who is going to pay for the miracle profits demanded by the manufacturers of these miracle products?
Diabetes
Hypertension
Cholesterol
Heart attacks
Stroke
Congestive heart failure
Autoimmune disorders
In terms of fortunes now being made and the industry’s impact on our economy, Big Pharma (or a little pharma that develops a miracle drug) is fast becoming today’s go-go industry. Profit margins often exceed those of industries, such as software, that we think of as modern gold mines. Only now the products have to do with life or death.
Amid the swirl of multi-billion dollar takeover deals generated by the prospects of a promising new drug,
can we trust these companies?
Can the data from the trials conducted to test their products that they submit to the Food and Drug Administration be trusted?
Can we rely on corporations that are looking over their shoulders at Wall Street not to inflate revenue
by selling a drug
to people that the FDA has walled off as targets
అండ్ for purposes that have not been sufficiently tested and for which the FDA has not granted approval?
Diabetes
Hypertension
Cholesterol
Heart attacks
Stroke
Congestive heart failure
Autoimmune disorders
In terms of fortunes now being made and the industry’s impact on our economy, Big Pharma (or a little pharma that develops a miracle drug) is fast becoming today’s go-go industry. Profit margins often exceed those of industries, such as software, that we think of as modern gold mines. Only now the products have to do with life or death.
Amid the swirl of multi-billion dollar takeover deals generated by the prospects of a promising new drug,
can we trust these companies?
Can the data from the trials conducted to test their products that they submit to the Food and Drug Administration be trusted?
Can we rely on corporations that are looking over their shoulders at Wall Street not to inflate revenue
by selling a drug
to people that the FDA has walled off as targets
అండ్ for purposes that have not been sufficiently tested and for which the FDA has not granted approval?
No comments:
Post a Comment